Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Operating Expenses | 4,724 | 7,364 | 7,288 | 423 |
| Operating Income | -4,724 | -7,364 | -7,288 | -423 |
| Other Income | -543 | -131 | -967 | 0 |
| Pre-tax Income | -5,267 | -7,495 | -8,255 | -423 |
| Net Income Continuous | -5,267 | -7,495 | -8,255 | -423 |
| Net Income | $-5,267 | $-7,495 | $-8,255 | $-423 |
| EPS Basic Total Ops | -0.05 | -0.10 | -0.14 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.10 | -0.14 | N/A |
| EPS Diluted Total Ops | -0.05 | -0.10 | -0.14 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.10 | -0.14 | N/A |
| EBITDA(a) | $-4,724 | $-7,364 | $-7,288 | $-423 |